AU Stock MarketDetailed Quotes
ACL Australian Clinical Labs Ltd
- 3.570
- -0.060-1.65%
20min DelayMarket Closed Nov 1 16:00 AET
719.91MMarket Cap29.75P/E (Static)
3.630High3.540Low787.34KVolume3.590Open3.630Pre Close2.82MTurnover3.85552wk High0.45%Turnover Ratio201.65MShares2.08152wk Low0.12EPS TTM620.91MFloat Cap5.250Historical High29.75P/E (Static)173.92MShs Float2.081Historical Low0.12EPS LYR2.48%Amplitude0.10Dividend TTM4.06P/B1Lot Size2.80%Div YieldTTM
About Australian Clinical Labs Ltd Company
Australian Clinical Labs, or ACL, is Australia’s third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.
Company Profile
SymbolACL
Company NameAustralian Clinical Labs Ltd
Founded2016
MarketASX
Employees4900
Fiscal Year Ends06-30
Address1868-1892 Dandenong Road
CityClayton
CountryAustralia
Zip Code3168
Phone+61 300453688
Share RegistryLINK MARKET SERVICES LIMITED
LEVEL 12, 680 GEORGE STREET, SYDNEY, NSW, AUSTRALIA, 2000
1300 554 474
Company Executives
- Name
- Position
- Salary
- Melinda McGrath
- Chief Executive Officer and Director
- --
- Michael Alscher
- Chairman of the Board
- --
- Nathanial Thon
- Director
- --
- Christine Bartlett, B.Sc. ,M.A.I.C.D.
- Independent Director
- --
- Andrew Dutton
- Independent Director
- --
- Dr. Leanne Rowe, A.M.,M.D.
- Independent Director
- --
- Mark Haberlin, B.Sc. ,F.C.A.
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data